Crinetics Pharmaceuticals
CRNX
#2695
Rank
ยฃ4.01 B
Marketcap
ยฃ43.32
Share price
-0.51%
Change (1 day)
65.09%
Change (1 year)

Revenue for Crinetics Pharmaceuticals (CRNX)

Revenue in 2024 (TTM): ยฃ0.82 Million

According to Crinetics Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is ยฃ0.81 Million. In 2023 the company made a revenue of ยฃ3.14 Million a decrease over the revenue in the year 2022 that were of ยฃ3.91 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Crinetics Pharmaceuticals from 2017 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ0.82 M-73.9%
2023 ยฃ3.14 M-19.55%
2022 ยฃ3.91 M390.29%
2021 ยฃ0.79 M
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA